State Agencies Sharpen Supplement Market Oversight During Pandemic, With Industry's Thanks
"We're particularly concerned about the health care area right now because obviously that's driving everything now," says Tennessee AG Herbert Slatery III. He and CRN CEO Steve Mister spoke with HBW Insight about regulation of the consumer health marketplace with FDA suspending inspections of facilities operated by businesses manufacturing and marketing products subject to its oversight.
You may also be interested in...
COVID-19 makes silver a gift that keeps on giving for US regulators with another business closed by court order; Seattle area naturopath charged with selling misbranded drug as a virus prevention; FTC reaches settlements with operators of “free trial” schemes for cosmetics and supplements; FDA announces criminal convictions of two men who defrauded the agency by misbranding steroid drugs they sold OTC.
In addition to 45 businesses with varying levels of communication skills the FTC targeted in its latest batch of warnings about false advertising linked coronavirus, the FDA "sent hundreds of abuse complaints to domain name registrars and internet marketplaces" also linked to bogus COVID-19 claims.
Dietary supplement industry trade groups say both the broader proposal and the narrow temporary rule are redundant because the state's attorney general already has enforcement authority against false and misleading claims for consumer health products.